HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Cover Story

Pancreatic cancer — a changing outlook if diagnosed early

Point/Counter

Should gemcitabine plus nab-paclitaxel be used in the adjuvant pancreatic cancer setting?

Editorial

Reflections on my 30th ASH Annual Meeting

John Sweetenham, MD

Guidelines

ASCO updates recommendations on venous thromboembolism prevention, treatment for patients with cancer

Meeting News

Antibody-drug conjugate provides ‘unprecedented’ benefit in metastatic HER2-positive breast cancer

Addition of S-1 to adjuvant endocrine therapy increases invasive DFS in breast cancer subset

Menopausal hormone therapy regimens have opposite lasting effects on breast cancer incidence

Sutimlimab demonstrates ‘rapid, sustained’ responses in cold agglutinin disease

Bispecific CAR T-cell therapy safe, effective for advanced multiple myeloma

Patients with CLL face ‘substantial burden’ of adverse events in real-world treatment setting

Researchers honored at San Antonio Breast Cancer Symposium

In the Journals

Invasive prostate cancer incidence rising among young men; cause elusive

Nivolumab shows promise in recurrent or metastatic cervical, vaginal/vulvar cancers

Flu vaccination shows modest efficacy among patients with cancer

FDA News

FDA approves Reblozyl for beta-thalassemia

FDA approves Ziextenzo, biosimilar to pegfilgrastim

FDA grants fast track designation to bemcentinib for acute myeloid leukemia

FDA approves Enhertu for HER2-positive breast cancer

Surgeon receives Association of Community Cancer Centers’ clinical scientist award

International Association for the Study of Lung Cancer appoints chief science officer